Tierney, Braden T.
Singh, Nitin K.
Simpson, Anna C.
Hujer, Andrea M.
Bonomo, Robert A.
Mason, Christopher E.
Venkateswaran, Kasthuri
Funding for this research was provided by:
WorldQuant Foundation
Starr Cancer Consortium (I13-0052, I13-0052, I13-0052)
National Institutes of Health (R01AI151059, R01AI151059, R01AI151059)
Bill and Melinda Gates Foundation (OPP1151054, OPP1151054, OPP1151054)
Alfred P. Sloan Foundation (G-2015-13964, G-2015-13964, G-2015-13964)
National Aeronautics and Space Administration (NNH12ZTT001N, NNH12ZTT001N)
Article History
Received: 7 May 2022
Accepted: 11 August 2022
First Online: 12 December 2022
Declarations
:
: No ethical approval or consent was needed for this manuscript.
: Not applicable.
: B.T.T works with Seed Health on microbiome study design and holds equity in the company. Seed Health was not involved in the funding or execution of this project. C.E.M is a co-founder of the Biotia and Onegevity Health. This manuscript was prepared as an account of work sponsored by NASA, an agency of the US Government. The US Government, NASA, California Institute of Technology, Jet Propulsion Laboratory, and their employees make no warranty, expressed or implied, or assume any liability or responsibility for the accuracy, completeness, or usefulness of information, apparatus, product, or process disclosed in this manuscript, or represent that its use would not infringe upon privately held rights. The use of, and references to any commercial product, process, or service does not necessarily constitute or imply endorsement, recommendation, or favoring by the US Government, NASA, California Institute of Technology, or Jet Propulsion Laboratory. Views and opinions presented herein by the authors of this manuscript do not necessarily reflect those of the US Government, NASA, California Institute of Technology, or Jet Propulsion Laboratory, and shall not be used for advertisements or product endorsements.